Link, H., Illerhaus, G., Martens, U., Salar, A., Depenbusch, R., Köhler, A., . . . Buchner, A. (2021). Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): Results of the randomized, open-label, non-inferiority AVOID neutropenia study.
Citación estilo ChicagoLink, Hartmut, et al. Efficacy and Safety of Lipegfilgrastim Versus Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-Hodgkin Lymphoma (B-NHL): Results of the Randomized, Open-label, Non-inferiority AVOID Neutropenia Study. 2021.
Cita MLALink, Hartmut, et al. Efficacy and Safety of Lipegfilgrastim Versus Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-Hodgkin Lymphoma (B-NHL): Results of the Randomized, Open-label, Non-inferiority AVOID Neutropenia Study. 2021.